Life Molecular Imaging

About Life Molecular Imaging (LMI)

Life Molecular Imaging (LMI, formerly Piramal Imaging) was formed in 2012 with the acquisition of the molecular imaging research and development portfolio of Bayer Pharma AG. It is now part of the Alliance Medical Group (a member of the Life Healthcare Group) offering an integrated business including research and development laboratories, a network of cyclotrons, radiopharmacies and imaging facilities.

By developing novel PET tracers for molecular imaging, LMI is focusing on a key field of modern medicine. The organisation strives to be a leader in the Molecular Imaging field by developing innovative products that improve early detection and characterisation of chronic and life-threatening diseases, leading to better therapeutic outcomes and improved quality of life.

Please visit https://life-mi.com.

For further details, please contact:

Alya Schalabi
European Pharma Collaboration and Marketing Manager

Cell: + 49 151 1456 9895
Email: a.schalabi@life-mi.com